Savient Pharmaceuticals, Inc. (VNT) Earnings
|
Expand Research on VNT
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +4.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | $0.80 | N/A | N/A | $737.24M | = | N/A | N/A | ||
| 2/12/26 | Q425 | $0.86 | $0.85 | +$0.01 | $808.5M | $764.99M | = |  | | Details | |
| 10/30/25 | Q325 | $0.78 | $0.77 | +$0.01 | $753M | $747.9M | = | | | Details | |
| 7/31/25 | Q225 | $0.79 | $0.72 | +$0.07 | $774M | $734.49M | = | | | Details | |
| 5/1/25 | Q125 | $0.77 | $0.72 | +$0.05 | $741M | $722.54M | = | | | Details | |
| 2/13/25 | Q424 | $0.80 | $0.79 | +$0.01 | $777M | $770.79M | = | | | Details | |
| 10/31/24 | Q324 | $0.73 | $0.69 | +$0.04 | $750M | $729.23M | = | | | Details | |
| 8/1/24 | Q224 | $0.63 | $0.70 | -$0.07 | $696.4M | $746.43M | = | | | Details |
